Clinical Edge Journal Scan

Clinical Edge Journal Scan

Adjuvant abemaciclib+ET shows treatment benefit regardless of menopausal status in HR+/HER2− early BC

• Read More

Clinical Edge Journal Scan

Adding ET to dual anti-HER2 targeted therapy beneficial in HER2+/HR+ metastatic BC

• Read More

Clinical Edge Journal Scan

SPIO can help avoid upfront sentinel lymph node dissection in ductal carcinoma in situ of the breast

• Read More

Clinical Edge Journal Scan

Contralateral prophylactic mastectomy offers no survival advantage in TNBC

• Read More

Clinical Edge Journal Scan

Adjuvant AI yields better survival outcomes than tamoxifen or tamoxifen+AI in HR+/HER2+ BC

• Read More

Clinical Edge Journal Scan

Commentary: Genetic variants, ovarian suppression, and metabolic syndrome in BC, February 2023

Author:

Yara Abdou, MD

• Read More

Clinical Edge Journal Scan

Metabolic syndromes worsen outcomes in BC patients treated with neoadjuvant chemotherapy

• Read More

Clinical Edge Journal Scan

Metastatic BC: Not worth changing the 4-weekly schedule of pegylated liposomal doxorubicin

• Read More

Clinical Edge Journal Scan

Early autologous fat grafting associated with increased BC recurrence risk

• Read More

Clinical Edge Journal Scan

Meta-analysis compares adjuvant chemotherapy regimens for resected early-stage TNBC

• Read More